Diversified Trust’s Core Laboratories CLB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q3
Sell
-1,750
Closed -$217K 300
2016
Q2
$217K Sell
1,750
-250
-13% -$30.2K 0.03% 347
2016
Q1
$225K Buy
2,000
+100
+5% +$10.4K 0.02% 352
2015
Q4
$207K Sell
1,900
-250
-12% -$28.6K 0.02% 390
2015
Q3
$215K Sell
2,150
-200
-9% -$21.8K 0.02% 393
2015
Q2
$268K Sell
2,350
-8,210
-78% -$996K 0.03% 398
2015
Q1
$1.1M Sell
10,560
-11,413
-52% -$1.22M 0.1% 213
2014
Q4
$2.64M Buy
+21,973
New +$2.89M 0.24% 90
2014
Q2
$4.39M Buy
+26,308
New +$4.68M 0.37% 42
2013
Q4
$5.29M Sell
27,693
-17,004
-38% -$3.16M 0.54% 21
2013
Q3
$7.56M Sell
44,697
-6,245
-12% -$969K 0.8% 14
2013
Q2
$7.73M Buy
+50,942
New +$7.22M 0.92% 14

Other funds holding CLB

Diversified Trust's CLB Position: Q3 2016 in Review

Diversified Trust sold out of Core Laboratories (CLB) in Q3 2016, closing a stake of 1,750 shares — an estimated $217K sold.

Diversified Trust first reported a position in CLB in Q2 2013 and held it in 11 quarters. The position peaked at $7.73M in Q2 2013. 372 funds tracked by Wall St. Rank hold CLB as of Q3 2016.

  • Diversified Trust reported no remaining Core Laboratories position as of Q3 2016 after selling out during the quarter.
  • Diversified Trust sold 1,750 Core Laboratories shares in Q3 2016, an estimated $217K.
  • Diversified Trust first reported a position in Core Laboratories in Q2 2013 and held it in 11 quarters.
  • Diversified Trust's Core Laboratories position peaked at $7.73M in Q2 2013.
  • 372 funds tracked by Wall St. Rank held Core Laboratories as of Q3 2016.

Based on Diversified Trust's 13F filing for Q3 2016, filed 3 Nov 2016.